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Background
Few population studies have described the heritability and intrafamilial 
concordance of the retinal microvessels, or the genetic or environmen-
tal correlations of the phenotypes of these vessels.
Methods
We randomly selected 413 participants from 70 families (mean age, 
51.5  years; 50.1% women) from a Flemish population. We post-
processed retinal images using IVAN software to generate the central 
retinal arteriole equivalent (CRAE), central retinal venule equivalent 
(CRVE), and arteriole-to-venule-ratio (AVR) from these images. We used 
SAGE version 6.2 and SAS version 9.2 to compute multivariate-adjusted 
estimates of heritability and intrafamilial correlations of the CRAE, 
CRVE, and AVR of the retinal microvessels in the images.
results
Sex, age, mean arterial pressure, and smoking explained up to 12.7% 
of the variance of the phenotypes of the retinal microvessels of the 
study participants. With adjustments applied for these covariates, the 
heritability estimates of CRAE, CRVE, and AVR were 0.213 (P = 0.044), 
0.339 (P  =  0.010), and 0.272 (P  =  0.004), respectively. The parent–off-
spring correlations for CRAE, CRVE, and AVR were 0.118 (NS), 0.225 
(P < 0.01), and 0.215 (P < 0.05), respectively. The corresponding values 
were 0.222 (P < 0.05), 0.213 (P < 0.05), and 0.390 (P < 0.001) for sib–sib 
correlations, respectively. The genetic and environmental correlations 
between CRAE and CRVE were 0.360 and 0.545 (P < 0.001 for both).
conclusion
Our study showed moderate heritability for CRAE, CRVE, and AVR, and a 
significant genetic correlation of CRAE with CRVE in the Flemish popu-
lation of our study. These findings suggest that genetic factors influ-
ence the diameter of the retinal microvessels, and that CRAE and CRVE 
share some genetic determinants.
Keywords: blood pressure; heritability; hypertension; micro circulation; 
retina.
doi:10.1093/ajh/hps064
Nonmydriatic imaging systems allow easy and noninvasive 
visualization of the retinal microvessels, and thereby provide 
a “window” to assess the microcirculation in the central ner-
vous system (CNS).1 Reduced arteriolar diameter predicts 
the risk of hypertension,2 stroke,3 and cardiovascular death.4 
Genome-wide linkage studies,5–8 although not consistent in 
identifying specifically responsible loci, have suggested that 
genetic factors contribute substantially to interindividual 
variation in the diameter of the retinal microvessels.
Heritability refers to the concordance in phenotypic traits 
between related individuals. Twin studies6,9,10 have found a 
range of from 56%–70% and of 62%–83% in the heritability 
of the central retinal arteriole equivalent (CRAE) and cen-
tral retinal venule equivalent (CRVE), respectively. To the 
best of our knowledge, only one previous study assessed the 
familial aggregation of the CRAE and CRVE in a popula-
tion–based cohort, of which 99% of the members were white 
Americans.11 In the present study, we assessed the heritabil-
ity, intrafamilial concordance, and genetic and environmen-
tal correlations of the diameters of the central retinal vessels 
in complex pedigrees randomly recruited from a Flemish 
population.
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Methods
study population
Previous reports provide a detailed description of 
the recruitment of the participants in the Flemish 
Study on Environment, Genes and Health Outcomes 
(FLEMENGHO).12 From August 1985 until November 
1990, a random sample was taken of the households in a 
geographically defined area of Northern Belgium with the 
goal of enrolling, in each of six subgroups, an equal number 
of participants on the basis of sex and age (20–39, 40–59, 
and ≥ 60 years). All household members with a minimum 
age of 20 years were invited to participate in the study, pro-
vided that the quotas for their groups in terms of sex and age 
had not yet been fulfilled. From June 1996 to January 2004, 
recruitment of families continued, with the participants in 
the 1985–1990 sample as index persons, with the added 
inclusion of subjects under 20  years of age. The participa-
tion rate at enrolment was 65.0%.12 From November 2007 to 
January 2012, we reinvited former participants to a follow-
up examination at our field center, which included imaging 
of their retinal microvessels. We obtained written informed 
consent from 662 of the participants in the earlier study (a 
rate of 75.3%). We excluded 132 singletons (unrelated par-
ticipants), and 117 participants in the earlier study because 
of poor-quality retinal images (n = 113), missing informa-
tion on covariates (n = 1), or outlying data points exceeding 
3 SD from the mean (n = 3). Our final analyses represented 
413 participants.
clinical and biochemical measurements
For at least 3 hours before the retinal examination for the 
study, the participants refrained from heavy exercise, smok-
ing, and intake of alcohol and caffeine-containing bever-
ages. Trained nurses measured the subjects’ anthropometric 
characteristics and blood pressure (BP). Body mass index 
(BMI) was calculated as the subject’s weight in kilograms 
divided by the square of the subject’s height in meters. The 
nurses also administered a questionnaire designed to collect 
information about each participant’s recent medical history, 
smoking and drinking habits, and intake of medications.
Each subject’s BP was recorded as the average of five con-
secutive readings taken after the subjects had rested in the 
sitting position for at least 5 minutes. Hypertension was 
defined as a BP of at least 140 mm Hg systolic or 90 mm 
Hg diastolic or the use of antihypertensive medication or 
both. Mean arterial pressure (MAP) was calculated as the 
diastolic BP (DBP) plus one third of the difference between 
the systolic BP and DBP. On the day of the retinal examin-
ation, with the subjects fasting for at least 8 hours, venous 
blood samples were drawn. Using standardized automated 
methods, we measured plasma glucose and serum total and 
high-density lipoprotein (HDL) cholesterol. We computed 
the Homeostasis Model Assessment-insulin resistance 
index (HOMA-IR) as the fasting serum insulin concentra-
tion multiplied by the fasting plasma glucose concentra-
tion with the product divided by 22.5. Diabetes mellitus 
was defined as a fasting plasma glucose concentration of 
6.99 mmol/l (126 mg/dl) or more or the use of antidiabetic 
medication.
Microvascular phenotyping
We phenotyped the subject’s retinal arterioles and venules 
as previously described.13 To dilate the pupil, retinal imag-
ing was done in a dimly lit examination room after the sub-
jects had accommodated to darkness for at least 5 minutes. 
Trained observers made photographs of each eye of each sub-
ject with a Canon Cr-DGi nonmydriatic retinal visualization 
system combined with a Canon D-50 digital camera (Canon, 
Kyoto, Japan). After converting JPEG to TIFF images, using 
the Phatch (http://photobatch.stani.be/) photographic and 
digital graphics processing system, two trained observers 
identified individual retinal arterioles and venules in each 
image, using the validated, computer-assisted IVAN pro-
gram (Vasculo-matic ala Nicola, version 1.1, Department 
of Ophthalmology and Visual Science, University of 
Wisconsin–Madison, Madison, WI).14 This software sys-
tem combines individual measurements of retinal blood 
vessels into the CRAE and the CRVE, which are summary 
indexes based on formulas developed by Parr and Spears,15 
Hubbard,16 and Knudtson.17 The arteriole-to-venule ratio 
(AVR) is calculated as the CRAE divided by the CRVE. The 
intraclass correlation coefficients of CRAE, CRVE, and AVR 
were 0.81, 0.63 and 0.70 for observer 1, respectively, and 0.69, 
0.71, and 0.70 for observer 2. The reproducibilities of CRAE, 
CRVE, and AVR were 13.2%, 8.4%, and 9.0%, respectively, 
for observer 1, and 10.3%, 10.8%, and 16.2, respectively, for 
observer 2.17 The interobserver reproducibilities of CRAE, 
CRVE, and AVR were 10.8%, 9.9% and 14.6%, respectively.18
statistical analysis
For management of the study database and statistical anal-
ysis, we used SAS software version 9.2 (SAS Institute, Cary, 
NC). We applied a logarithmic transformation to normalize 
the distributions of insulin and insulin resistance determined 
with the HOMA index. The central tendency and spread of 
the distributions were presented as the arithmetic mean 
(±SD) or geometric mean (interquartile range). We com-
pared means and proportions through the use of Student’s 
t-test and the chi-squared test, respectively. Our statistical 
methods also included single and multiple linear regres-
sions. We searched for possible covariates of the arterial phe-
notypes through a stepwise regression procedure with the 
P-values for independent variables to enter and to stay in the 
model set at 0.15. As covariates we considered sex, age, BMI, 
MAP, the ratio of HDL to total cholesterol, the HOMA-IR, 
and design variables (0, 1), coding for current smoking, alco-
hol intake, and the use of various classes of antihypertensive 
drugs (diuretics, beta-blockers, vasodilators, and inhibitors 
of the renin–angiotensin–aldosterone system). To estimate 
heritability and to calculate the intrafamilial and genetic and 
environmental correlations of the retinal vascular measures 
examined in the study, we used the 2012 Statistical Analysis 
for Genetic Epidemiology (S.A.G.E.) software pack-
age, release 6.2 (http://darwin.cwru.edu/) (S.A.G.E., Case 
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Western Reserve University, Cleveland, OH). We applied 
the ASSOC and the FCOR procedures of S.A.G.E. software 
to respectively assess heritability and intrafamilial corre-
lations in the narrow sense. We estimated heritability by 
assuming multivariate normality after a simultaneously esti-
mated power transformation. The ASSOC procedure of the 
S.A.G.E. software uses a multiple linear regression model in 
which the residual variance is partitioned into the sum of 
an additive polygenic component, a sibling component, and 
an individual-specific random component. The FCOR pro-
cedure estimates familial correlations and their asymptotic 
standard errors via the Pearson product-moment method. 
Heritability (h2) was estimated as the polygenic component 
divided by the total residual variance.
We calculated the genetic and environmental correlations 
between CRAE and CRVE with adjustments applied for 
covariates. With the assumption of a lack of dominance vari-
ance and no interaction between the genetic and environ-
mental variance components, the variance of a trait is given 
by: V = G + E, where G is the additive polygenic component 
and E is the environmental component. The total phenotypic 
correlation between two traits (ρP) can be partitioned into a 
genetic (ρG) and an environmental (ρE) component given 
by the equation:
ρP = ρG√h12h22 + ρE√(1 – h12)(1 – h22)
where h12 and h22 represent the heritability of the two traits, 
and ρG and ρE are the genetic and environmental correla-
tions, respectively. The significance of ρG and ρE suggests 
the influence of shared genes and shared environmental fac-
tors on two traits.19 We compared ρG and ρE using Fisher’s 
Z transformation.
results
characteristics of study participants
Our study sample included 413 subjects from 70 com-
plex pedigrees with sizes ranging from 2 to 37 individuals 
and encompassing from 1 to 3 generations. Table  1 lists 
the characteristics of the study participants by generation. 
Compared with the first generation, the second generation 
more frequently reported drinking but less frequently used 
antihypertensive drugs. As compared with the second gener-
ation, the third generation had lower values of BMI, BP, and 
total cholesterol, but had a higher HDL-to-total cholesterol 
ratio, less frequently reported drinking alcohol. and had a 
lower prevalence of hypertension.
determinants of retinal microvascular phenotypes
In our stepwise regression analysis (Table 2), the covari-
ates considered for entry into the model were sex, age, BMI, 
MAP, HDL-to-total cholesterol ratio, HOMA-IR value, 
smoking, drinking of alcohol, and antihypertensive drug 
treatment. Sex and age were forced into the model. The 
CRAE was larger in women than in men and in smokers 
than in nonsmokers, and was inversely and independently 
associated with age and MAP. The same tendencies were 
observed for CRVE. The AVR was higher in women than in 
men and tended to decrease with age. The amount of vari-
ance explained ranged from 2.1% to 12.7%.
heritability, genetic, and environmental correlation
We estimated the h2 of retinal-vessel diameters, using 
incremental adjustments. Our model 1 included sex and 
age as covariates; model 2 was additionally adjusted for 
MAP; model 3 also included current smoking; and model 
4 additionally accounted for antihypertensive drug treat-
ment. The heritability estimates for CRAE, CRVE, and 
AVR were significant (h2 ≥ 0.213; P ≤ 0.044) with the excep-
tion of that for CRAE in model 1 (h2 ≥ 0.201; P = 0.064). 
The heritability estimates ranged from 0.201 to 0.252 for 
CRAE, from 0.281 to 0.339 for CRVE, and from 0.272 to 
0.310 for AVR. The heritability estimates for body height 
and weight, computed as a reference, were 0.389 and 0.492, 
respectively, and 0.754 and 0.531 when adjusted for sex 
and age (Table  3). The total adjusted phenotypic correla-
tion (ρP) of CRAE with CRVE was significant (ρP = 0.490; 
P < 0.001; Figure 1), and we therefore partitioned it into a 
genetic (ρG) and an environmental (ρE) component. The 
genetic correlation was significant (ρG = 0.360, P < 0.001), 
although weaker (P = 0.0008) than the environmental cor-
relation (ρE = 0.545, P < 0.001).
Familial correlation
With adjustment applied as in Table  3, the sib–sib corre-
lations (n = 176) ranged from 0.213 to 0.390 (P ≤ 0.015) for 
the retinal phenotypes, and were 0.441 (P = 0.0001) and 0.391 
(P = 0.0003) for body height and weight, respectively (Table 4). 
The adjusted parent–offspring correlations (n  =  174) were 
significant for CRVE (r = 0.225; P = 0.009), AVR (r = 0.215; 
P = 0.0154), body height (r = 0.397; P < 0.0001), and weight 
(r = 0.325; P = 0.013).
discussion
In the family-based population study described here, we 
observed a moderate but significant heritability of retinal 
microvascular phenotypes. The sib–sib correlations were 
significant for all of the phenotypes that we assessed, but 
the parent–offspring correlations were significant only for 
CRVE and AVR, and not for CRAE. One possible interpre-
tation of these findings is that all retinal microvascular phe-
notypes are genetically determined, and that the influence of 
environmental factors is stronger for CRAE than for CRVE. 
Our study adds to the existing literature because: (i) in con-
trast to twin studies,6,9,10 our participants represented an 
unbiasedm randomly recruited population sample; (ii) we 
estimated both heritability and intrafamilial correlations in 
the same study participants,6,9–11 (iii) in contrast to previous 
studies,6,10,11 we partitioned the total phenotypic correlation 
between CRAE and CRVE into genetic and environmental 
components; (iv) our analyses were more comprehensively 
adjusted than those in other studies6,9–11; and (v) we used a 
nonmydriatic method to obtain our retinal images.6,9–11
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Table 2. Determinants of retinal vascular phenotypes 
Determinant CRAE CRVE AVR
R2 0.127 0.073 0.021
Regression coefficients
Female 4.19 ± 1.38† 1.82 ± 1.95 0.013 ± 0.006*
Age (+10 years) –1.58 ± 0.49† –1.30 ± 0.71 –3.55 ± 2.06 (×10–2)
Mean arterial pressure (+10 mm Hg) –2.63 ± 0.66‡ –1.92 ± 0.93* …
Smoker 3.82 ± 1.61* 8.39 ± 2.27‡ …
*P < 0.05; †P < 0.01; ‡P < 0.001
Abbrevaitions: AVR, arteriole-to-venule ratio; CRAE, central retinal arteriole equivalent; CRVE, central retinal venule equivalent.
The covariables considered for entry into the model were sex, age, body mass index, mean arterial pressure, ratio of high-density lipid cho-
lesterol to total cholesterol, Homeostasis Assessment Model-insulin resistance, smoking and drinking, and antihypertensive drug treatment. 
Sex and age were forced into the models.
Table 1. Characteristics of study participants 
Characteristic Generation 1 Generation 2 Generation 3
Number 142 85 186
Arithmetic mean (± SD)
 Age, years) 62.1 ± 9.3 54.2 ± 8.8‡ 42.2 ± 14.9‡
 Body mass index, kg/m2 27.7 ± 4.5 27.2 ± 3.9 25.5 ± 4.2†
 Systolic blood pressure, mm Hg 131.5 ± 17.1 127.8 ± 16.2 122.3 ± 13.8†
 Diastolic blood pressure, mm Hg 81.5 ± 9.0 81.8 ± 10.7 77.2 ± 11.1†
 Mean arterial pressure, mm Hg 98.2 ± 10.2 97.2 ± 11.7 92.2 ± 11.0‡
 Total cholesterol, mmol/l 5.42 ± 0.87 5.39 ± 0.91 4.96 ± 0.88‡
 HDL cholesterol, mmol/l 1.43 ± 0.36 1.43 ± 0.35 1.42 ± 0.32
 Ratio of HDL-to-total cholesterol 0.267 ± 0.066 0.270 ± 0.076 0.293 ± 0.074*
 Plasma glucose, mmol/l 5.06 ± 0.62 5.06 ± 0.91 4.92 ± 0.90
 Central retinal arteriole equivalent, μm 151.4 ± 15.9 152.9 ± 13.0 153.8 ± 14.7
 Central retinal venule equivalent, μm 215.3 ± 20.4 220.1 ± 20.6 219.0 ± 19.8
 Arteriole-to-venule ratio 0.706 ± 0.069 0.698 ± 0.060 0.705 ± 0.060
Geometric mean, 95% IQR
 Insulin, mU/l 5 (3 to 9) 6 (4 to 10) 5 (3 to 9)
 HOMA insulin resistance 1.21 (0.69 to 1.89) 1.18 (0.77 to 2.29) 1.11 (0.64 to 2.06)
Subjects with characteristic, n (%)
 Current smoking 37 (26.1) 20 (23.5) 41 (22.0)
 Drinking alcohol 41 (28.9) 38 (44.7)* 60 (32.3)*
 Hypertension 52 (36.6) 23 (27.1) 27 (14.5)*
 Diabetes 1 (0.70) 0 1 (0.54)
Antihypertensive drug treatment 37 (26.1) 7 (8.2)‡ 13 (7.0)
 Diuretics 16 (11.3) 5 (5.9) 3 (1.6)
 Beta-blockers 27 (19.0) 4 (4.7)† 11 (5.9)
 Vasodilators 6 (4.2) 3 (3.5) 0*
 RAAS inhibitors 8 (5.6) 0* 1 (0.54)
*P < 0.05; †P < 0.01; ‡P < 0.001, significance of difference between generations.
Hypertension was defined as a blood pressure ≥ 140 mm Hg systolic or ≥ 90 mm Hg diastolic, or the use of antihypertensive drugs. Diabetes 
was defined as a fasting plasma glucose concentration ≥ 6.99 mmol/l or the use of antidiabetic drugs. Vasodilators included calcium antagonists 
and alpha-blockers. Renin–angiotensin–aldosterone system inhibitors included converting enzyme inhibitors and angiotensin II receptor blockers.
Abbreviations: HDL, high-density lipoprotein; HOMA, Homeostasis Assessment Model; IQR, interquartile range; RAAS, renin-angiotensin-
aldosterone system.
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Figure 1. Genetic and environmental correlations between central retinal arteriolar equivalent (CRAE) and central retinal venular equivalent (CRVE). 
Correlation coefficients were adjusted as in model 4 (Table 3). Abbreviations: ρP, total phenotypic correlation; ρG, genetic correlation; ρE, environmental 
correlation. Values on ordinate are correlation coefficients (95% confidence interval).
Table 3. Heritability of retinal vascular phenotypes and anthropometric characteristics 
Unadjusted Model 1 Model2 Model 3 Model 4
h2 ± SE P value h2 ± SE P value h2 ± SE P value h2 ± SE P value h2 ± SE P value
CRAE 0.252 ± 0.137 0.033 0.201 ± 0.132 0.064 0.214 ± 0.124 0.042 0.213 ± 0.125 0.044 0.214 ± 0.124 0.043
CRVE 0.281 ± 0.159 0.038 0.300 ± 0.147 0.021 0.309 ± 0.145 0.017 0.339 ± 0.146 0.010 0.337 ± 0.144 0.010
AVR 0.310 ± 0.105 0.002 0.273 ± 0.106 0.005 0.273 ± 0.105 0.005 0.272 ± 0.104 0.004 0.274 ± 0.102 0.004
Body height 0.389 ± 0.154 0.006 0.754 ± 0.104 < 0.0001 … … … … … …
Body weight 0.492 ± 0.124 < 0.0001 0.531 ± 0.112 < 0.0001 … … … … … …
All models were adjusted for sex and age. Models 2, 3, and 4 were additionally adjusted respectively for mean arterial pressure, mean arterial 
pressure plus current smoking, mean arterial pressure plus smoking, and antihypertensive drug treatment.
Abbreviations: AVR, arteriole-to-venule ratio; CRAE, central retinal arteriole equivalent; CRVE, central retinal venule equivalent.
Table 4. Familial correlations of retinal vascular phenotypes and anthropometric characteristics 
Spouse–spouse (n = 90) Parent–offspring (n = 174) Sib–sib (n = 176)
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
CRAE 0.080 0.090 0.134 0.118 0.316† 0.222*
CRVE 0.156 0.207 0.204* 0.225† 0.273† 0.213*
AVR 0.204 0.040 0.158 0.215* 0.135 0.390‡
Body height 0.188 0.064 0.301† 0.397‡ 0.278† 0.441‡
Body weight 0.270† 0.129 0.261 0.325* 0.127 0.391‡
*P < 0.05; †P < 0.01; ‡P < 0.001.
All adjustments include sex and age, and for retinal phenotypes also include mean arterial pressure, smoking, and use pf antihypertensive drugs.
Abbreviations: AVR, arteriole-to-venule ratio; CRAE, central retinal arteriole equivalent; CRVE, central retinal venule equivalent.
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In keeping with other studies, 6,9–11 we noticed that CRAE 
tended to have a lower heritability than CRVE. In a genome-
wide association study, Ikram and colleagues observed asso-
ciations of CRVE with four loci (19q13, 6q24, 12q24, and 
5q14), whereas none of the associations for CRAE reached 
genome-wide significance. Ikram et al. speculated that the 
genetic influence on CRAE might be attenuated because of 
the overriding effects of age and BP on the retinal micro-
vasculature. The Australian Twins Eye Study involved 374 
monozygotic and 536 dizygotic twin pairs and 322 sib-
lings.6 With adjustments applied for sex, age, and BMI, 
but not BP, the heritability estimates for CRAE and CRVE 
in the Tasmanian study were 59.4% and 61.7% and 56.5% 
and 64.2% in the Brisbane study. A  study in Copenhagen 
of the association of retinal arterial and venous diameter 
with the risk of cardiovascular disease involved 55 monozy-
gotic and 18 dizygotic, same-sex healthy twin pairs.10 The 
Danish researchers adjusted for sex, age, smoking, choles-
terol, and glucose tolerance in various combinations, but 
did not present analyses adjusted for all covariates in com-
bination.10 Heritability estimates in the Danish study were 
70% for CRAE and 83% for CRVE.10 As exemplified by our 
current findings and the literature that we reviewed,6,9,10 her-
itability estimates in twin studies are usually larger than in 
population surveys because of the use of different methods 
of statistical estimation20 or because twins may share a com-
mon environment to a greater extent than do members of 
complex pedigrees, and if so, a portion of the environmen-
tal factors that twins share may be partitioned into genetic 
variance. Heritability estimates usually decrease with more 
comprehensive adjustment.
In the present study we also computed intrafamilial cor-
relation coefficients. Simple product-moment correlation 
coefficients can be used as a measure of the degree of con-
cordance (positive correlations) or discordance (negative 
correlations) of a trait between family members, as sug-
gested in 1979 by the Framingham investigators.21 However, 
these correlation coefficients do not eliminate the problem 
of using a particular individual’s data more than once, such 
as when correlating information between parents and off-
spring or between sibs.
We found significant sib–sib correlations for CRAE, 
CRVE, and AVR. However, the parent–offspring correla-
tions were significant only for CRVE and AVR. In the Beaver 
Dam Eye Study,11 with adjustment for sex, age, MAP, and 
smoking, the sib–sib correlations for CRAE, CRVE, and 
AVR were 0.20, 0.23 and 0.12, respectively. The correspond-
ing parent–offspring correlations were 0.27, 0.24, and 0.16. 
Thus, in the Beaver Dam Eye Study,11 the parent–offspring 
and sib–sib correlations were similar. However, the avuncu-
lar correlations amounted to about half of the parent–off-
spring correlations, and the cousin correlations were half of 
the avuncular correlations.11 As in the current study, none of 
the spouse–spouse correlations in the Beaver Dam Eye Study 
was significant.11 The investigators in the study concluded 
that the pattern of correlations that they observed was con-
sistent with a genetic component for CRVE and AVR.11 In 
their study, CRAE also showed some genetic component, 
but also seemed to be influenced by environmental factorsm 
as reflected by the similar avuncular and cousin correlations 
found in the study.11
We partitioned the total phenotypic correlation between 
CRAE and CRVE into a genetic and an environmental com-
ponent. The correlations of the genetic and environmental 
components were 0.360 and 0.545, respectively. Host factors, 
such as age, MAP, and lifestyle, including smoking, might 
explain why the environmental correlation was greater than 
the genetic correlation. Fahy et  al.9 estimated the genetic 
and environmental correlations of CRAE with CRVE in 706 
monozygotic and 757 dizygotic white female twins. They 
partitioned the covariance between CRAE and CRVE into 
additive genetic, common environmental, and unique envi-
ronmental factors,9 and assumed that the correlation between 
latent genetic factors was 1.0 in monozygotic twins and 0.5 
in dizygotic twins. They found that 77% of the covariance 
between CRAE and CRVE was due to additive genetic fac-
tors, with the remaining 23% attributable to unique environ-
mental effects.9 Fahy et al. replicated these findings in 1981 
in twins from the Australian Twins Eye Study.9 When com-
paring our results in the present study with those reported 
by Fahy et al., one should keep in mind that heritability esti-
mates are usually higher in twins than in complex pedigrees 
recruited from populations,20 and that the methods used to 
compute the genetic and environmental contributions in our 
study and the study by Fahy et al. were different.
Our study should be interpreted within the context of its 
potential limitations. First, our sample size was relatively 
small, especially in terms of the number of families that con-
sisted of two or more generations. This might have explained 
the relatively low heritability of the retinal-vessel diameters 
found in our study. However, the heritability and intrafa-
milial correlations of body height and weight in our study 
were comparable with those reported in previous popula-
tion20,22,23 and twin24 studies, suggesting that our study was 
adequately statistically powered. Moreover, EkstrØm et  al. 
found that 200–400 individuals are generally sufficient to 
provide reasonably robust estimates of heritability as defined 
in our present study.25
Second, we did not prove the natural descent of the off-
spring in our study. However, in a prior study based on the 
same population as in the present study,20 only two parent–
offspring relations had to removed, on the basis of Mendelian 
inconsistency in the ABO and Rhesus blood-type groups. 
These two parent–offspring pairs were not included in the 
current study. Third, we did not exclude participants being 
treated with antihypertensive drugs. However, adjustment 
for treatment and other covariates did not affect our results. 
Lastly, we did not adjust for refractive errors. However, pre-
vious studies showed that correction for refraction did not 
materially alter estimates of heritability and intrafamilial 
correlations.11 Furthermore, refractive error might influence 
CRAE and CRVE, but not AVR,26 which in the present study 
showed significant heritability.
In conclusion, our findings in the study described here 
suggest that genetic factors influence the diameter of the ret-
inal microvessels. Estimates of heritability of retinal micro-
vascular phenotypes were little affected when BP was taken 
into account, suggesting that the genes involved might not 
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necessarily act through BP, in accord with the finding in sev-
eral studies that retinal arteriolar narrowing may precede the 
development of hypertension,27–30 cardiovascular disease,31 
and stroke.3 The significant genetic correlation between arte-
riolar and venular diameters suggests that these traits share 
some common genetic determinants. Genetic factors may 
also directly influence the structure and function of the reti-
nal microvasculature.
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